The PGIM Jennison Health Sciences Fund lagged its index in Q1 2026 despite strength in biotech and M&A activity. Read the full analysis for more details.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results